Treatment of pancreatic adenocarcinoma: a European perspective

Dirk J Gouma; Olivier R C Busch; Thomas M van Gulik

doi:10.1016/j.soc.2008.02.005

Treatment of pancreatic adenocarcinoma: a European perspective

Surg Oncol Clin N Am. 2008 Jul;17(3):569-86, ix. doi: 10.1016/j.soc.2008.02.005.

Authors

Dirk J Gouma¹, Olivier R C Busch, Thomas M van Gulik

Affiliation

¹ Department of Surgery, Academic Medical Center of the University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands. d.j.gouma@amc.uva.nl

PMID: 18486884
DOI: 10.1016/j.soc.2008.02.005

Abstract

The diagnostic strategy/staging, surgical management, and adjuvant treatment of pancreatic cancer have changed worldwide during the past decades. These changes are discussed in this article. Specific attention is given to European studies and contributions.

Publication types

Review

MeSH terms

Adenocarcinoma / diagnosis
Adenocarcinoma / drug therapy
Adenocarcinoma / radiotherapy
Adenocarcinoma / surgery
Adenocarcinoma / therapy*
Chemotherapy, Adjuvant
Europe
Hormones / therapeutic use
Humans
Neoplasm Staging
Palliative Care / methods
Pancreatic Neoplasms / diagnosis
Pancreatic Neoplasms / drug therapy
Pancreatic Neoplasms / radiotherapy
Pancreatic Neoplasms / surgery
Pancreatic Neoplasms / therapy*
Probiotics / therapeutic use
Radiotherapy, Adjuvant
Somatostatin / therapeutic use

Substances

Hormones
Somatostatin